Literature DB >> 8238744

Controversies in primary breast cancer management.

D W Kinne1.   

Abstract

Adequate locoregional treatment of patients with primary operable breast cancer involves the control of multicentric disease in the breast and axillary dissection to stage the disease and control it in the axilla, when present. Two options, having equal survival rates in prospective, randomized studies, are breast preservation and mastectomy. In breast preservation, adequate tumor excision with clear histologic margins and axillary dissection is followed by breast irradiation. The mastectomy option involves no radiotherapy and can be followed by reconstruction. Careful selection of patients and a detailed description of the pros and cons of each approach should be undertaken on an individual basis.

Entities:  

Mesh:

Year:  1993        PMID: 8238744     DOI: 10.1016/s0002-9610(05)81144-4

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  The reliability of sampling three to six nodes for staging breast cancer.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

Review 2.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

3.  Intraoperative assessment of axillary lymph node metastases in operable breast cancer.

Authors:  M Noguchi; M Minami; M Earashi; T Taniya; I Miyazaki; Y Mizukami; A Nonomura
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4. 

Authors:  P Schäfer
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

5.  Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 6.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

8.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

Review 9.  Improved axillary staging of breast cancer with sentinel lymphadenectomy.

Authors:  A E Giuliano; P S Dale; R R Turner; D L Morton; S W Evans; D L Krasne
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.